DAFTAR PUSTAKA

Aherne, S.A., and O’Brien, N.M., 1999, Protection by the flavonoids myricetin,
quercetin, and rutin against hydrogen peroxide-induced DNA damage in
Caco-2 and HepG2 cells, Nutrition and cancer 34: 160–166.

Amico, V., Barresi, V., Chillemi, R., Condorelli, D.F., Sciuto, S., Spatafora, C.,
and Tringali, C., 2009, Bioassay-guided isolation of antiproliferative
compounds from grape (Vitis vinifera) stems, Natural product
communications 4 (1): 27-34.

American Cancer Society, 2010, Chemotherapy principles: an in-depth discussion

of the techniques and its role in cancer treatment, http://www.
www.cancer.org/chemotherapy-principles-pdf, diakses pada tanggal 5
September 2015.

Ames, B.N., Gold, L.S., and Willet, W.C., 1995, The causes and prevention of
cancer, Proceedings of the national academy of sciences 92: 5258–5265.

Anderson, D., Bishop, J. B., Garner, R. C., Ostrosky-Wegman, P., and Selby, P.
B., 1995, Cyclophosphamide: review of its mutagenicity for an
assessment of potential germ cell risks, Mutation research/fundamental
and molecular mechanisms of mutagenesis 1: 115-181.

Anderson, R.F., Amarasinghe, C., Fisher, L.J., Mak, W.B., and Packer, J.E., 2000.
Reduction in free-radical-induced DNA strand breaks and base damage
through fast chemical repair by flavonoids, Free radical research 33: 91–
103.

Anonim, 1995, Materia medika indonesia, Jilid VI, 119-123, Departemen

Kesehatan Republik Indonesia, Jakarta.

Anonim, 2013, Cyclophosphamide for injection and tablets package insert, Baxter
Healthcare Corporation, Deerfield-USA.

Aomori, T., Yamamoto, K., Oguchi-Katayama, A., Kawai, Y., Ishidao, T., Mitani,
Y., ... and Horiuchi, R., 2009, Rapid single-nucleotide polymorphism
detection of cytochrome P450 (CYP2C9) and vitamin K epoxide

60
 61

reductase (VKORC1) genes for the warfarin dose adjustment by the

SMart-amplification process version 2, Clinical chemistry 4: 804-812.

Argmann, C.A., Chambon, P., and Auwerx, J., 2005, Mouse phenogenomics: the
fast track to “systems metabolism”, Cell metabolism 6: 349-360.

Arumugam, N., Sivakumar, V., Thanislass, J., Pillai, K.S., Devaraj, S.N., and
Devaraj, H., 1999, Acute pulmonary toxicity of acrolein in rats-
underlying mechanism, Toxicology letters 3: 189-194.

Arwansyah, Ambarsari, L., and Sumaryada, T.I., 2014, Simulasi docking senyawa
kurkumin dan analognya sebagai inhibitor reseptor androgen pada kanker
prostat, Current biochemistry 1 (1): 11-19.

Asyhar, 2008, Modulasi ekspresi protein n-ras ekstrak etanolik rumput mutiara
(Hedyotis corymbosa) pada sel hepar tikus galur sprague dawley
terinduksi 7,12-dimetilbenz[a]antra-sena), Prosiding Kongres Ilmiah XVI
ISFI, Cancer Chemoprevention Research Center (CCRC), Fakultas
Farmasi Universitas Gadjah Mada.

Backer, C.A. and Van Den Brink, R.C.B., 1965, Flora of Java: Spermatophytes
only Volume III, N.V.P. Noordhoff-Groningen-The Netherlands.

Bertz, R.J., and Granneman, G.R., 1997, Use of in vitro and in vivo data to
estimate the likelihood of metabolic pharmacokinetic interactions,
Clinical pharmacokinetics 3: 210-258.

Bonassi, S., Biasotti, B., Kirsch-Volders, M., Knasmueller, S., Zeiger, E., Burgaz,
S., ... and HUMNXL Project Consortium, 2009, State of the art survey of
the buccal micronucleus assay—a first stage in the HUMNXL project
initiative, Mutagenesis 4: 295-302.

Bont, Rinne De and Larebeke, Nik van., 2004, Review: endogenous DNA damage
in humans: a review of quantitative data, Mutagenesis 19: 169–185.

Boone, C.W., Steele, V.E., and Kelloff, G.J., 1992, Screening for chemo-
preventive (anticarcinogenic) compounds in rodents, Mutation research/
fundamental and molecular mechanisms of mutagenesis 2: 251-255.
 62

Boonstra, J., and Post, J.A., 2004, Molecular events associated with reactive
oxygen species and cell cycle progression in mammalian cells, Gene 337:
1–13.

Brulikova, L., Hlavac, J., and Hradil, P., 2012, DNA interstrand cross-linking
agents and their chemotherapeutic potential, Current medicinal chemistry
19: 364-385.

Bryce, S.M., Shi, J., Nicolette, J., Diehl, M., Sonders, P., Avlasevich, S., Raja, S.,
Bemis, J.C., and Dertinger, S.D., 2010, High content flow cytometric
micronucleus scoring method is applicable to attachment cell lines,
Environmental and molecular mutagenesis 51: 260–266.

Calvert, P.M., and Frunct, H., 2002, The Genetics of colorectal cancer, Annals of
internal medicine 137: 603-612.

Cerutti, P., Hussain, P., Pourzand, C, and Aguilar, F., 1994, Mutagenesis of the
H-ras protooncogene and the p53 tumour suppressor gene, Cancer
research 54: 1934–1938.

Chen, Y.H., Chang, F.R., Wu, C.C., Yen, M.H., Liaw, C.C., Steelman, L.S., et al.,
2005, New cytotoxic 6-oxigenated 8,9-hedyotiscone a-c, from Hedyotis
biflora, Planta medica 72: 75-78.

Chen, Y., Guo, Y., Ge, X., Itoh, H., Watanabe, A., Fujiwara, T., ... and Aburatani,
H., 2006, Elevated expression and potential roles of human Sp5, a
member of Sp transcription factor family, in human cancers, Biochemical
and biophysical research communications 3: 758-766.

Chinnaswamy, G., Errington, J., Foot, A., Boddy, A. V., Veal, G. J., and Cole,
M., 2011, Pharmacokinetics of cyclophosphamide and its metabolites in
paediatric patients receiving high-dose myeloablative therapy, European
journal of cancer 10: 1556-1563.

Clayson, D.B., Mehta, R., and Iverson, F., 1994, Oxidative DNA damage — The
effects of certain genotoxic and operationally non-genotoxic carcinogens,
Mutation research/reviews in genetic toxicology 1: 25-42.
 63

Cooke, M.S., Evans, M.D., Dizdaroglu, M., and Lunec, J., 2003, Oxidative DNA
damage: mechanisms, mutation, and disease, Federation of american
societies for experimental biology journal 17: 1195–1214.

Corlett, S.A., and Chrystyn, H., 1996, High-performance liquid chromatographic

determination of the enantiomers of cyclophosphamide in serum, Journal
of chromatography b: biomedical sciences and applications 682: 337–
342.

Criswell, K.A., Khrisna, G., Zielinski, D., Urda, G.A., Theisis, J.C., Juneau, P.,
and Bleavin, M.R., 1998, Use of acridine orange in flow cytometric
assessment of micronuclei induction, Mutation research 414 (1-3): 63-
75.

Crook, T.R., Souhami, R.L., and McLean, A.E., 1986, Cytotoxicity, DNA cross-
linking, and single strand breaks induced by activated cyclophosphamide
and acrolein in human leukemia cells, Cancer research 46: 5029–5034.

Czemplik, M., Żuk, M., Kulma A., Kuc1, S., and Szop, J., 2011, GM flax as a
source of effective antimicrobial compounds, Formatex 1216-1224.

Damian, E.B., James, H.W., Lucinda, L., Debbie, H., Darren, K., Sarah, M.G.,
Gareth, P., Carol, B., and David, J.K., 2011, Evaluation of a multi-
endpoint assay in rats, combining the bone-marrow micronucleus test, the
Comet assay and the flow-cytometric peripheral blood micronucleus test,
Mutation research 722: 7–19.

Deferme, L., Briedé, J.J., Claessen, S.M.H., Cavill, R., and Kleinjans, J.C.S.,
2015, Cell line-specific oxidative stress in cellular toxicity: A
toxicogenomics-based comparison between liver and colon cell models,
Toxicology in vitro 29: 845-855.

Dizdaroglu, M., and Jaruga, P., 2012, Mechanisms of free radical-induced

damage to DNA, Free radical research 46: 382–419.

Dollery, C., 1999, Cyclophosphamide, In: Dollery, C. (Ed.), Therapeutic drugs,

Churchill Livingstone, Edinburg, pp. 349–353.

Dong-Kyoo, Kim., Jin, H.B., Chang, M. K., Mi, A.Y., Jae, W.S., Dong, K.K., et
al., 2000, Apoptotic activity of ursolic acid may correlate with the
 64

inhibition of initiation of dna replication, International journal of cancer

87: 629–636.

Drablos, F., Feyzi, E., Aas, P.A., Vaagbo, C.B., Kavli, B., Bratlie, M.S., et al.,
2004, Alkylation damage in DNA and RNA—Repair mechanisms and
medical significance, DNA repair (Amst.) 3: 1389–1407.

Duthie, S.J., and Dobson, V.L., 1999. Dietary flavonoids protect human
colonocyte DNA from oxidative attack in vitro, European journal of
nutrition 38: 28–34.

Eichelbaum, M., Ingelman-Sundberg, M., and Evans, W.E., 2006,

Pharmacogenomics and individualized drug therapy, Annual review of
medicine 57: 119-137.

Ekroos, M., and Sjögren, T., 2006, Structural basis for ligand promiscuity in
cytochrome P450 3A4, Proceedings of the National Academy of Sciences
103 (37): 13682-13687.

Farghali, A.A, and Abo-Zeid Mona, A.M., 2009, Evaluation of the antimutagenic
effect of vitamin C against DNA damage and cytotoxicity induced by
trimethyltin in mice, Natural sciences.

Fenech, M., 2008, The micronucleus assay determination of chromosomal level

DNA damage, In Environmental genomics (pp.185-216), Humana Press.

Fenech, M., Bonassi, S., Turner, J., Lando, C., Ceppi, M., Chang, W. P., ... and
Zijno, A., 2003, Intra-and inter-laboratory variation in the scoring of
micronuclei and nucleoplasmic bridges in binucleated human
lymphocytes: Results of an international slide-scoring exercise by the
HUMN project, Mutation research/genetic toxicology and environmental
mutagenesis 1: 45-64.

Ferguson, L.R., 2001, Role of plant polyphenols in genomic stability, Mutation

research 475: 89–111.

Ferguson, L.R., Philpot, M., and Karunasinghe, N., 2004, Dietary cancer and
prevention using antimutagens, Toxicology 198: 147–159.
 65

Ferrari, C.K.B., 2000, Free radicals, lipid peroxidation, and antioxidants in

apoptosis: implications in cancer, cardiovascular and neurological
diseases, Biologia 55: 581–590.

Franssen, C., Boekema, P., De Witte, T., Wessels, J., Van der Kogel, A., and
Haanen, C., 1990, DNA strand breaks in human leukocytes induced by
chemotherapy and total body irradiation, Leukemia research 14: 91-97.

Fridovich, I., 1999, Fundamental aspects of reactive oxygen species, or what’s the
matter with oxygen?, Annals of the new york academy of sciences 893:
13–18.

Frighetto, R.T.S., Rodolfo, W.M., Eduardo, N.N., Nélson, F., and Antonio, S.C.,
2008, Isolation of ursolic acid from apple peels by high speed counter-
current chromatography, Food chemistry 106: 767-771.

Galassetti, A.P., 2006, Dietary effects on oxidation of low-density lipoprotein and

atherogenesis, Current atherosclerosis reports 8: 523–529.

Gilgun-Sherki, Y., Melamed, E., and Daniel, 2001, Offen Oxidative stress
induced-neurodegenerative diseases: the need for antioxidants that
penetrate the blood brain barrier, Neuropharmacology 40: 959–975.

Girija, C.R., Karunakar, P., Poojari, C.S., Begum, N.S., Syed, A.A., 2010,
Molecular docking studies of curcumin derivative with multiple protein
targets for procarcinogen activating enzyme inhibition, Journal of
Proteomics and Bioinformatics 3 (6): 200-203.

Goldberg, M.A., Antin, J.H., Guinan, E.C., and Rappeport, J.M., 1986.
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor,
Blood 68: 1114–1118.

Green, L.J and Lin, S-Yih., 2012, DNA Damage Response and Breast Cancer: An
Overview, Targeting New Pathways and Cell Death in Breast Cancer,
Dr. Rebecca Aft (Ed.), InTech.

Greene, M.H., Harris, E.L., Gershenson, D.M., Malkasian, G.D., Melton, L.J.,
Dembo, A.J., ... and Boice, J.D., 1986, Melphalan may be a more potent
leukemogen than cyclophosphamide, Annals of internal medicine 3: 360-
367.
 66

Guengerich, F.P., 1999, Cytochrome P450 3A4: regulation and role in drug
metabolism, Annual review of pharmacology and toxicology 1: 1-17.

Guengerich, F.P., 2007, Cytochrome P450 and chemical toxicology, Chemical

research in toxicology 1: 70-83.

Haas, O.A., Chott, A., Ladenstein, R., and Gadner, H., 1987, Poorly
differentiated, neuron‐specific enolase positive round cell tumor with two
translocations t (11; 22) and t (21; 22), Cancer 9: 2219-2223.

Hariana, H.A., 2006, Tumbuhan obat & khasiatnya 3, Niaga Swadaya.

Hart, S.N., and Zhong, X.B., 2008, P450 oxidoreductase: genetic polymorphisms
and implications for drug metabolism and toxicity.

Hartmann, A., Agurell, E., Beevers, C., Smith, A., Speit, G., and Thybaud, V.,
2003, Recommendations for conducting the in vivo alkaline Comet
assay, Mutagenesis 18: 45–51.

Haryanti, S., 2008, Efek Ekstrak Etanolik Hedyotis corymbosa L. terhadap

Aktivitas Sitotoksik Doxorubicin pada Sel MCF-7, Tesis, Universitas
Gadjah Mada, Yogyakarta, Indonesia.

Haryanti, S., Junedi, S., and Meiyanto, E., 2009, Ethanolic Extract of Hedyotis
corymbosa L. Increases Cytotoxic Activity of Doxorubicin on MCF-7
Breast Cancer Cell, Indonesian journal of biotechnology 14 (1): 1146-
1154.

Hasler, J.A., Estabrook, R., Murray, M., Pikuleva, I., Waterman, M., Capdevila,
J., ... and Beaune, P., 1999, Human cytochromes P450, Molecular
aspects of medicine 1: 1-137.

Hayashi, J., Mac Gregor, D., Gatehouse, D., Blakey, S., Dertinger, L.,.….and D.
Gibson, 2007, In vivo erythrocyte micronucleus assay III. Validation and
regulatory acceptance of automated scoring and the use of rat peripheral
blood reticulocytes, with discussion of non-hematopoietic target cells and
a single dose-level limit test, Mutation research 627: 10–30.
 67

Hayashi, M., Tice, R.R., MacGregor, J.T., Anderson, D., Blakey, D.H., Kirsch-
Volders, M., Oleson, F.B. jr, Pacchierotti, F., Romagna, F., Shimada, H.,
Sutou, S., and Vannier, B., 1994, In vivo rodent erythrocyte
micronucleus assay, Mutation research 312 (3): 293-304.

Heddle, J.A., 1973, A rapid in vivo test for chromosomal damage, Mutation
research/fundamental and molecular mechanisms of mutagenesis 2: 187-
190.

Heinig, R., Adelmann, H. G., and Ahr, G., 1999, The effect of ketoconazole on
the pharmacokinetics, pharmacodynamics and safety of nisoldipine,
European journal of clinical pharmacology 1: 57-60.

Heinonen, O.P., and Albanes, D., 1994, The Effect of Vitamin E and Beta
Carotene on the Incidence of Lung Cancer and Other Cancers in Male
Smokers, The new england journal of medicine 330: 1029-1035.

Helleday, T., Petermann, E., Lundin, C., Hodgson, B., and Sharma, R.A., 2008,
DNA repair pathways as targets for cancer therapy, Nature reviews
cancer 8: 193–204.

Holland, J.F., Kufe, D.W., Weichselbaum, R.R., Pollock, R.E., Frei, E., and
Gansler, T.S., 2003, Cancer medicine 6th Ed., BC Decker: Hamilton, ON,
Canada.

Holland, N., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., Zeiger, E.,
Knasmueller, S., and Fenech, M., 2008, The micronucleus assay in
human buccal cells as a tool for biomonitoring DNA damage: the HUMN
project perspective on current status and knowledge gaps, Mutation
research/ reviews in mutation research 1: 93-108.

Hosseinimehr, S.J, and Karami, M., 2005, Citrus extract modulates genotoxicity
induced by cyclophosphamide in mice bone marrow cells, Journal of
pharmacy and pharmacology 4: 505-509.

Huang, Z., Roy, P., and Waxman, D.J., 2000, Role of human liver microsomal
CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of
cyclophosphamide and ifosfamide, Biochemical pharmacology 8: 961-
972.
 68

Hui, W.H., and Lam, C.N., 1964, The occurrence of triterpenoids and steroids in
some plants of the Rubiaceae family of Hong Kong, Australian journal
of chemistry 4: 493-495.

Hurley, 2002, DNA and Its Associated Processes as Targets for Cancer Therapy,
Macmillan magazine march.

Hutchinson, 1959, The Families of Flowering Plants, The Clarendon Press,

Oxford.

IARC, 1981, Some antineoplastic and immunosuppressive agents, IARC

monographs on the evaluation of carcinogenic risks to humans, you are
here: home 26: 1–411, PMID: 6944253.

Ingelman-Sudberg, M., 2004, Human drug metabolisir cytochrome P450

enzymes: properties and polymorfism, Naunyn-Schmiedeberg’s archives
of pharmacology 369: 89-104.

Jamura, M.C., Grodzkia, A.C.G., Morenob, A.N., De Mellob, L.C., Pastora,

M.V.D.,.......and Olivera, C., 2001, Identification and isolation of rat
bone marrow-derived mast cells using the mast cell-specific monoclonal
antibody, Journal of histochemistry and cytochemistry 49: 219-28.

Johansson, I., and Ingelman-Sundberg, M., 2011, Genetic polymorphism and

toxicology--with emphasis on cytochrome P450, Toxicological sciences
1: 1–13.

Jones, E., Fox, V., Elliott, B.M., and Moore, N.P., 2001, The mutagenic potential
of acetonitrile in the bone marrow and peripheral blood of the mouse,
Mutagenesis 2: 151-154.

Karol, K.G., Luiz, G., and Eva, R., 2009, Genotoxic and cytotoxic effects
produced by acetogenins obtained from Annona cherimolia Mill.,
Biological and pharmaceutical bulletin 12: 2346-2349.

Kastan, M., and Bartek, J., 2004, Cell-Cycle Checkpoints And Cancer, Nature
432: 316–323.
 69

Kawanishi, S., Hiraku, Y., Murata, M., and Oikawa, S., 2002, The role of metals
in site-specific DNA damage with reference to carcinogenesis, Free
radical biology and medicine 32: 822–832.

Khastgir, H., Sengupta, S.K., and Sengupta, P., 1960, Note on the constituents of
the Indian medicinal plant Oldenlandia corymbosa Linn., Journal of
american pharmacists association, 49: 562-563.

Kim, E., Sy-Cordero, A., Graf, T.N., Brantley, S.J., Paine, M.F., Oberlies, N.H.,
2011, Isolation and identification of intestinal CYP3A inhibitors from
cranberry (Vaccinium macrocarpon) using human intestinal microsomes,
Planta medica 77 (3): 265-70.

Kinlen, L.J., 1985, Incidence of cancer in rheumatoid arthritis and other disorders
after immunosuppressive treatment, The American journal of medicine 1:
44-49.

Kirsch-Volders, M., and Fenech, M., 2001, Inclusion of micronuclei in non-

divided mononuclear lymphocytes and necrosis/apoptosis may provide a
more comprehensive cytokinesis block micronucleus assay for
biomonitoring purposes, Mutagenesis 1: 51-58.

Konstandi, M., Johnson, E.O., and Lang, M.A., 2014, Consequences of

psychophysiological stress on cytochrome P450-catalyzed drug
metabolism, Neuroscience and biobehavioral reviews 45: 149-167.

Korb, O., Stutzle, T., and Exner, T.E., 2006, PLANTS: Application of ant colony
optimalization to structure-based drug design, Lecture notes in computer
science 4150: 247-258.

Koul, A., Gangar, S.C., and Sandhir, V., 2005, Pitfalls in journey from traditional
to modern medicine, Natural product radiance 4: 6-13.

Krishna, G., and Hayashi, M., 2000, In vivo rodent micronucleus assay: protocol,
conduct and data interpretation, Mutation research 455: 155-166.

Kuo, P.L., Hsu, Y.L., Lin, L.T., and Lin, C.C., 2005, Isoliqquiritigenin inhibits
cell proliferation and induces apoptpsis in human hepatoma cells, Planta
medica 2: 130-134.
 70

Lee, H.Z., Bau, D., Kuo, C.L., Tsai, R.Y., Hen, Y.C., and Chan, Y.H., 2011,
Clarification of the phenotypic characteristics and anti-tumor activity of
Hedyotis diffusa, The American journal of chinese medicine (world
scientific) 1: 201-213.

Leila, J. Green, and Shiaw-Yih, Lin., 2012, DNA damage response and breast
cancer: an overview, Targeting new pathways and cell death in breast
cancer, Dr. Rebecca Aft (Ed.), ISBN: 978-953-51-0145-1, InTech.

Lin, H.L., Liu, T.Y., Chau, G.Y., Lui, W.Y., and Chi, C.W., 2000, Comparison of
2‐methoxyestradiol‐induced, docetaxel‐induced, and paclitaxel‐induced
apoptosis in hepatoma cells and its correlation with reactive oxygen
species, Cancer 5: 983-994.

Liu, J., 1995, Pharmacology of oleanolic acid and ursolic acid, Journal of
ethnopharmacology 49: 57–68.

Liu, J., 2005, Oleanolic acid and ursolic acid : research perspective, Jounal of
ethnopharmacology 100: 92-94.

Loft, S., and Poulsen, H.E., 1996, Cancer risk and oxidative DNA damage in man,
Journal of molecular medicine 6: 297-312.

Lusiyanti, Y., and Wa’id, A., 1999, Mikronuklei sebagai Dosimetri Biologi,
Buletin ALARA 3: 21-26.

MacGregor, M.E., Bishop, S.D., Dertinger, J., McNamee, M.M., Moore, A.

Aidoo, S., et al., 2004, A flow cytometric assay that permits integration
of chromosomal damage assessment with routine toxicity testing, Annual
meeting, Society of toxicology, Baltimore, Abstract.

Majer, B.J., Laky, B., Knasmuller, S., and Kassie, F., 2001, Use of the
micronucleus assay with exfoliated epithelial cells as a biomarker for
monitoring individuals at elevated risk of genetic damage and in
chemoprevention trials, Mutation research (2–3):147–172.

Martin-Aragon, S., de las Heras, B., Sanchez-Reus, M.I., and Benedi, J., 2001,
Pharmacological Modication of Endogenous Antioxidant Enzymes by
Ursolic Acid on Tetrachloride-Induced Liver Damage in Rats and
 71

Primary Cultures of Rat Hepatocytes, Experimental and toxicological

pathology 53: 199–206.

Matchar, D.B., Thakur, M.E., Grossman, I., McCrory, D.C., Orlando, L.A.,….and
Gray, R.N., 2007, Testing for cytochrome p450 polymorphisms in adults
with nonpsychotic depression treated with selective serotonin reuptake
inhibitors (SSRIs), Evidence report/technology assessment no. 146
(prepared by the duke evidence-based practice center under contract no.
290-02-0025.) ahrq publication no. 07-e002, Rockville, MD: Agency for
Healthcare Research and Quality.

McCarroll, N., Keshava, N., and Cimino, M., 2008, An evaluation of the mode of
action framework for mutagenic carcinogens case study:
Cyclophosphamide, Environmental and molecular mutagenesis 49: 117–
131.

McGraw, J., and Waller, D., 2012, Cytochrome P450 variations in different ethnic
populations, Expert opinion on drug metabolism and toxicology 3: 371
382.

Meirow, D., Epstein, M., Lewis, H., Nugent, D., and Gosden, R.G., 2001,
Administration of cyclophosphamide at different stages of follicular
maturation in mice: effects on reproductive performance and fetal
malformations, Human reproduction 4: 632-637.

Meiyanto, E., Febriansah, R., Asyhar, A., Jenie, R.I., Sukamdi, D.P., and Ashari,
R. A., 2010, Peningkatan ekspresi p53 oleh ekstrak etanolik rumput
mutiara (Hedyotis corymbosa) pada sel hepar tikus Sprague Dawley
Terinduksi 7, 12-Dimetilbenz [A] Antrasena.

Mirkes, P.E., 1985, Cyclophosphamide teratogenesis: a review, Teratogenesis,

carcinogenesis, and mutagenesis 2: 75-88.

Mitscher, L.A., Telikepalli, H., McGhee, E., and Shankel, D.M., 1996, Natural
antimutagenic agents, Mutation research 350: 143 – 152.

Moore, F.R., Urda, G.A., Krishna, G., and Theiss, J.C., 1995, An in vivo/in vitro
method for assessing micronucleus and chromosome aberration induction
in rat bone marrow and spleen. 1, Studies with cyclophosphamide,
Mutation research 335: 191–199.
 72

Moore, M.J., 1991, Clinical pharmacokinetics of cyclophosphamide, Clinical

pharmacokinetics 20:194–208.

Muhtadi, 2012, Carconigenic, http://indramuhtadi.weebly.com/4/category/-

carcinogenic/1.html, diakses pada 16 Oktober 2015.

Mythili, M.D., Vyas, R., Akila, G., and Gunasekaran, S., 2004, Effect of
streptozotocin on the ultrastructure of rat pancreatic islets, Microscopy
research and technique 63: 274–281.

Nadendla, R.R., 2004, Molecular modeling: A powerful tool for drug design and
molecular docking, Resonance 9: 51-60.

Nathoo, S.A., and Marshall, M.V., 2002, Genotoxic assessment of BriteSmile

Whitening Procedure Gel in the mouse micronucleus test, Journal of
dental research 81: A211-A211.

Neri, M., Fucic, A., Knudsen, L.E., Lando, C., Merlo, F., and Bonassi, S, 2003,
Micronuclei frequency in children exposed to environmental mutagens:
A review, Mutation research (2–3): 243–254.

Neuvonen, P.J., and Jalava, K.M., 1996, Itraconazole drastically increases plasma
concentrations of lovastatin and lovastatin acid, Clinical pharmacology
and therapeutics 1: 54-61.

Neuvonen, P.J., Kantola, T., and Kivistö, K.T., 1998, Simvastatin but not
pravastatin is very susceptible to interaction with the CYP3A4 inhibitor
itraconazole, Clinical pharmacology and therapeutics 3: 332-341.

Niemi, M., Backman, J.T., Fromm, M.F., Neuvonen, P.J., and Kivistö, K.T.,
2003, Pharmacokinetic interactions with rifampicin, Clinical
pharmacokinetics 9: 819-850.

Olkkola, K.T., Ahonen, J., and Neuvonen, P.J., 1996, The effects of the systemic
antimycotics, itraconazole and fluconazole, on the pharmacokinetics and
pharmacodynamics of intravenous and oral midazolam, Anesthesia and
analgesia journal 82.
 73

Ovesná, Z., Vachálková, A., Horváthová, K., and Tóthová, D., 2004, Pentacyclic
triterpenoic acids: new chemoprotective compounds. Minireview,
Neoplasma 51 (5): 327-333.

Owen, R.W., W. Mier, A. Giacosa, W. E. Hull, B. Spiegelhalder, and H. Bartsch,

2000, Phenolic compounds and squalene in olive oilsthe concentration
and antioxidant potential of total phenols, simple phenols, secoiridoids,
lignans and squalene, Food and chemical toxicology 38: 647-659.

Pascoe, S., and Gatehouse, D., 1986, The use of a simple haematoxylin and eosin
staining procedure to demonstrate micronuclei within rodent bone
marrow, Mutation research 164 (4): 237-43.

Patel, T.D., Jain, V., and Dodia, R., 2014, Oldenlandia corymbosa L.: A
Phytopharmacologicalreview, International journal of phytopharmacy 3:
79-82.

Pebriana, R.B., Romadhon, A.F., Yunianto, A., Rokhman, M.R., Fitriyah, N.Q.,
Jenie, R.I., and Meiyanto, E., 2008, Docking kurkumin dan senyawa
analognya pada reseptor progesteron: studi interaksinya sebagai selective
progesterone receptor modulators (SPRMs), Pharmacon 9 (1): 14-20.

Phillips, K.A., Veenstra, D. L., Oren E., Lee, J.K., and Sadee, W., 2001, Potential
rol of pharmacogenomics in reducing adverse drug reactions: a
systematic review, JAMA 286: 2270-2279.

Pritchard, M.T., McMullen, M.R., Stavitsky, A.B., Cohen, J.I., Lin, F., Medof, M.
E., and Nagy, L.E., 2007, Differential contributions of C3, C5, and
decay-accelerating factor to ethanol-induced fatty liver in mice,
Gastroenterology 3: 1117-1126.

Purnomo, H., 2011, Kimia komputasi: molecular docking PLANTS, Pustaka

Pelajar, Yogyalarta.

Ramos A.A., Lima C.F., Pereira M.L., Fernandes-Ferreira M., and Pereira-Wilson
C., 2008, Antigenotoxic Effects of Quercetin, Rutin and Ursolic Acid on
HepG2 Cells: Evaluation by the Comet Assay, Toxicology letters 177:
66–73.
 74

Rasoanaivo, P., Wright, C.W., Willcox, M.L., Gilbert, B., 2011, Whole plant
extracts versus single compounds for the treatment of malaria: synergy
and positive interactions, Malaria journal 10: 1-12.

Redbook, F.D.A., 2000, IV.C.1.d Mammalian Erythrocyte Micronucleus

Test. Toxicological Principles for the Safety Assessment of Food
Ingredients, diakses melalui http://www.fda.gov/food/guidancecompli-
anceregulatoryinformation/guidancedocuments/foodingredientsandpacka
ging/redbook/ucm078338.htm pada tanggal 10 Oktober 2015.

Rendic, S., and Di Carlo, F.J., 1997, Human cytochrome P450 enzymes: a status
report summarizing their reactions, substrates, inducers, and inhibitors,
Drug metabolism reviews 29: 413–580.

Ribeiro, D. A., Grilli, D. G., and Salvadori, D. M., 2008, Genomic instability in
blood cells is able to predict the oral cancer risk: an experimental study in
rats, Journal of molecular histology 5: 481-486.

Rodriguez-Antona, C., and Ingelman-Sundberg, M., 2006, Cytochrome P450

pharmacogenetics and cancer, Oncogene 11: 1679-1691.

Ross, J.A., and Kasum, C.M., 2002. Dietary flavonoids: bioavailability, metabolic
effects, and safety, Annual review of nutrition 22: 19–34.

Roy, P., Li, J.Y., Crespi, C.L., and Waxman, D.J., 1999, Development of a
substrate-activity based approach to identify the major human liver P-450
catalysts of cyclophosphamide and ifosfamide activation based on
cDNA-expressed activities and liver microsomal P-450 profiles, Drug
metabolism and disposition 6: 655-666.

Ruddon, R.W., 2007, Cancer Biology, Edisi Keempat, Oxford University Press
Inc, New York, page 62, 82, 92, 493.

Sadasivan, S., Latha, P.G., Sasikumar, J.M., Rajashekaran, S., Shyama, S., and
Shine, V.J., 2006, Hepatoprotective studies on Hedyotis corymbosa (L.)
Lamk., Journal of ethnopharmacology 106 (2006): 245-249.

Sala, A., Recio, M.D., Giner, R.M., Manez, S., Tournier, H., Schinella, G., and
Rios, J.L., 2002, Anti-inflammatory and antioxidant properties of
 75

Helichrysum italicum, Journal of pharmacy and pharmacology 54 (3):

365-371.

Saleh, K., and Sarhan, M., 2007, Clastogenic analysis of chicken farms using
micronucleus test in peripheral blood, Journal of applied sciences
research 3: 1646-1649.

Sanderson, B.J., and Shield, A.J., 1996, Mutagenic damage to mammalian cells
by therapeutic alkylating agents, Mutation research/fundamental and
molecular mechanisms of mutagenesis 1: 41-57.

Santos, J.L., Bosquesi, P.L., Almeida, A.E., Chin, C.M., and Varanda, E.A., 2011,
Mutagenic and genotoxic effect of hydroxyurea, International journal of
biomedical science 7 (4): 263-267.

Saravanan, R., Viswanathan, P., and Pugalendi, K.V., 2005, Protective effect of
ursolic acid on ethanol-mediated experimental liver damage in rats, Life
sciences 78: 713–718.

Sarmoko, 2008, Uji sitotoksik ekstrak etanolik daun sirihan (Piper aduncum L.)
terhadap sel kanker payudara dan prediksi interaksi senyawa calkon
terhadap reseptor berdasarkan molecular docking, Skripsi, Fakultas
Farmasi Universitas Gadjah Mada, Yogyakarta.

Sasikumar, J.M., Maheshu, V., Aseervatham, G.S., and Darsini, D.T., 2010, In
vitro antioxidant activity of Hedyotis corymbosa (L.) Lam. aerial parts,
Indian journal of biochemistry and biophysics 1: 49-52.

Schlegel, R., and Mac Gregor, J.T., 1982, The persistence of micronuclei in
peripheral-blood erythrocytes-detection of chronic chromosome breakage
in mice, Mutation research 104: 367-369.

Schmid, 1975, The micronucleus test, Mutation research 31: 9–15.

Scott, A.D., Orsi A.C., Ward, C., and Bradford, R., 2012, Genotoxicity testing of
a Hoodia gordonii extract, Food and chemical toxicology 50: 34–40.

Selvan, P.S., Vellavan, S., Sagunthala, P., Prakash, N., and Subramanian, D.S.,
2015, Analysis of phytochemical component and nutrients component in
 76

ethanol extracted Oldenlandia corymbosa, World journal of

pharmaceutical research.

Senthil, S., Sridevi, M., and Pugalendi, K.V., 2007, Cardioprotective effect of
oleanolic acid on isoproterenol-induced myocardial ischemia in
rats, Toxicologic pathology 3: 418-423.

Shabrina, B.A., 2015, Efek Antigenotoksik ekstrak etanolik daun pepaya (Carica
Papaya L.) pada mencit (Mus musculus) galur swiss terinduksi
siklofosfamid melalui mammalian in vivo micronucleus test, Skripsi,
Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.

Shigenaga, M.K., Ames, B.N., and Hagen, T.M., 1993, Oxidants, antioxidants,
and the degenerative diseases of aging, Proceedings of the national
academy of sciences 90: 7915-7922.

Shimada, T., 2006, Xenobiotic-metabolizing enzymes involved in activation and

detoxification of carcinogenic polycyclic aromatic hydrocarbons, Drug
metabolism and pharmacokinetics 4: 257-276.

Shishodia, S., Majumdar S., Banerjee S., and Aggarwal B.B., 2003, Ursolic acid
inhibits nf-κb activation induced by carcinogenic agents through
suppression of iκbα kinase and p65 phosphorylation: correlation with
down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and
cyclin d1, Cancer research 15: 4375-4383.

Shon, Y.H., and Nam, K.S., 2003, Inhibition of cytochrome P450 isozymes in rat
liver microsomes by polysaccharides derived from Phellinus linteus,
Biotechnology letters 2: 167-172.

Singh, D., Kashyap, A., Pandey, R.V., and Saini, K. S., 2011, Novel advances in
cytochrome P450 research, Drug discovery today 17: 793-799.

Sivapraksam, S.S.K., Karunakaran, K., Subburaya, U., Kuppusamy, S., and

Subashini, T.S., 2014, A reiview on phytochemical and pharmacological
profile of Hedyotis corymbosa Linn, International journal of
pharmaceutical sciences review and research 54: 320-324.

Sladek, N.E., 1971, Metabolism of cyclophosphamide by rat hepatic

microsomes, Cancer research 6: 901-908.
 77

Sladek, N.E., 1988, Metabolism of oxazaphosphorines, Pharmacology and

therapeutics 3: 301-355.

Song, H., 2007, Studies on teh abstraction of triterpenoid acids in Hedyotis

corymbosa, Herald of medicine 3: 281-282.

Sudarsono, Gunawan, D., Wahyuono, S., Donatus, I. A., and Purnomo, 2002,
Tumbuhan Obat II, Cetakan I, 104-105, Yogyakarta, Pusat Studi Obat
Tradisional Universitas Gadjah Mada.

Sugiyanto, R., 2014, Menakar potensi antigentotoksik kayu secang (Caesalpinia

Sappan L.) dalam prevensi kerusakan dna melalui mnpce assay in vivo,
Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.

Sumanth, M., and Chowdary, G.N., 2010, Antimutagenic activity of aqueous

extract of Momordica charantia, International journal of biotechnology
and molecular biology research I 4: 42-6.

Suparman, 2008, Efek ekstrak etanolik rumput mutiara (Hedyotis corymbosa L.)
terhadap aktivitas sitotoksik doksorubicin pada sel kanker kolon WiDr,
Tesis, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Suzuki, Y., Nagae, Y., Li, J., Sakaba, H., Mozawa, K., Takahashi, A., and
Shimizu, H., 1989, The micronucleus test and erythropoiesis. Effects of
erythropoietin and a mutagen on the ratio of polychromatic to
normochromatic erythrocytes (P/N ratio), Mutagenesis 4: 420–424.

Swift, L.H., and Golsteyn, R.M., 2014, Genotoxic anti-cancer agents and their
relationship to dna damage, mitosis, and checkpoint adaptation in
proliferating cancer cells, International journal of molecular sciences 15:
3403–3431.

Testa, B., Pedretti, A., and Vistoli, G., 2012, Reactions and enzymes in the
metabolism of drugs and other xenobiotics, Drug discovery today 11:
549-560.

The Collaborative Study Group for the Micronucleus Test, CSGMT., 1986, Sex
difference in the micronucleus test, Mutation research 172: 151-163.
 78

Tripathi, D.N., and Jena, G.B., 2009, Intervention of astaxanthin against

cyclophosphamide-induced oxidative stress and DNA damage: a study in
mice, Chemico-biological interactions 180: 398–406.

Tweats, D., Blakely, D., Heflich, R.H., Jacobs, A., Jacobsen,.…and Tice, R.,
2007a, Report of the IWGT working group on strategies and
interpretation of regulatory in vivo tests I. Increases in micronucleated
bone marrow cells in rodents that do not indicate genotoxic hazards,
Mutation research 627: 78-91.

Tweats, D.J., Blakely, D., Heflich, R.H., Jacobs, A., Jacobsen, S.D., Morita, T.,
…..and Tice, R., 2007b, Report of the IWGT working group on
strategy/interpretation for regulatory in vivo tests. II. Identification of in
vivo-only positive compounds in the bone marrow micronucleus test,
Mutation research 627: 92-105.

Uttara, B., Singh, A.V., Zamboni, A.V., and Mahajan, R.T., 2009, Oxidative
stress and neurodegenerative diseases: a review of upstream and
downstream antioxidant therapeutic options,Current neuropharmacology
7: 65–74.

Varhe, A., Olkkola, K.T., and Neuvonen, P.J., 1994, Oral triazolam is potentially
hazardous to patients receiving systemic antimycotics ketoconazole or
itraconazole, Clinical pharmacology and therapeutics 6: 601-607.

Velmurugan, M., Selvanayagam, Cengiz E.I.E., and Unlu, E., 2007, Histo-
pathology of lambda-cyhalothrin on tissues (gill, kidney, liver and
intestine) of Cirrhinus mrigala, Environmental toxicology and
pharmacology 24: 286–291.

Vilar, J.B., Ferreira, F.L., Ferri, P.H., Guillo, L.A., and Chen Chen, L., 2008,
Assessment of the mutagenic, antimutagenic and cytotoxic activities of
ethanolic extract of araticum (Annona crassiflora Mart. 1841) by
micronucleus test in mice, Brazilian journal of biology 1: 141-147.

Vredenburg, G., den Braver-Sewradj, S., van Vugt-Lussenburg, B. M.,

Vermeulen, N. P., Commandeur, J. N., and Vos, J. C., 2015, Activation
of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome
P450 BM3 mutants, Toxicology letters 1: 182-192.
 79

Waters, M.D., Brady, A.L., Stack, H.F., and Brockman, H.E., 1990,
Antimutagenicity profiles for some model compounds, Mutation
research 238: 57–85.

Watkins, P.B., 1995, Cyclosporine and liver transplantation: will the midazolam
test make blood level monitoring obsolete? Hepatology 22: 994–996.

Weijun, L., 1992, Improvement of micronucleus test method in peripheral blood

lymphocytes and preliminary observations in clinical use, Chinese
journal of medical testing 4: 233-234.

Wijayakusuma, H.M.H., Dalihmarta, S., Winar, A.S., 1992, Tanaman berkasiat

obat di Indonesia, Jilid I, Pustaka Kartini Ikapi Jaya, Jakarta.

Wogan, G. M., Hecht, S. S., Felton, J. S., Conney, A. H., and Loeb, L.A., 2004,
Environmental and chemical carcinogenesis, Seminars in cancer biology
14: 473–486.

Wójciak-Kosior, M., 2007, Application of high performance thin-layer

chromatography to separation of oleanolic, ursolic and betulinic acids,
Journal of pre-clinical and clinical research 1: 176-178.

Yadav, R.N.S and Agarwala, M., 2011, Phytochemical analysis of some

medicinal plants, Journal of phytology 3 (12): 10-14.

Yang, C.W., Chen, Y.H., Chan, F.R., Wu, C.C., Yen, M.H., Liaw, C.C., Huang,
H.C., and Kuo, Y.H., 2005, New Cytotoxic 6-Oxygenated 8,9-
Dihydrofurocumarins, Hedyotiscone A-C, from Hedyotis Biflora, Planta
medica 72: 75-78.

Yin, H., Racha, J., Li, S.Y., Olejnik, N., Satoh, H., and Moore, D., 2000,
Automated high throughput human CYP isoform activity assay using
SPE-LC/MS method: application in CYP inhibition
evaluation, Xenobiotica 2: 141-154.

Yoon, J.-H., Bhatia, G., Prakash, S., and Prakash, L, 2010, Error-free replicative
bypass of thymine glycol by the combined action of DNA polymerases j
and f in human cells, Proceedings of the national academy of sciences
107: 14116–14122.
 80

Yun-Zhong, F., Sheng, Y., and Guoyao, W.u., 2002, Free radicals, antioxidants
and nutrition, Nutrition 18: 872–879.

Zekri, A.R.N., Sabry, G.M., Bahnassy, A.A., Shalaby, K.A., Wahabh, S.A.A., and
Zakaria, S., 2005, Mismatch repair genes (hMLH1, hPMS1, hPMS2,
GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular
carcinoma, The World journal of gastroenterology 20: 3020-3026.

Zhang, Q., Kang, X., and Zhao, W., 2006, Antiangiogenic effect of low-dose
cyclophosphamide combined with ginsenoside Rg3 on Lewis lung
carcinoma, Biochemical and biophysical research communications 3:
824-828.

Zhou, B.B.S., and Elledge, S.J., 2000, The DNA damage response: putting
checkpoints in perspective, Nature 6811: 433-439.

Zhou, J.J., Xie, G., and Yau, X.J., 2002, Traditional chinese medicines :
molecular structure, natural sources and application, 2nd Ed., Ashgate
Published, Hampsire-England.